GO
Loading...

Medtronic PLC

More

  • After stroke, clot removal saves brain function - studies Wednesday, 11 Feb 2015 | 12:00 PM ET

    The two studies used devices made by Covidien, which was acquired by Medtronic PLC last month and helped pay for one of the trials. Stryker Corp and privately-held Penumbra Inc also manufacture devices approved for clot removal. Patrick Lyden, director of the Stroke Program at Cedars-Sinai Medical Center in Los Angeles, who was not involved in the studies.

  • Allergan Actavis

    M&A experts forecast there will be more major pharma deals in 2015 — but the U.K. won’t be a focus and the deals won’t be done for tax reasons.

  • Why one VC is investing, despite seeing a bubble Tuesday, 3 Feb 2015 | 11:07 AM ET
    Entrepreneur

    Joe Horowitz has been in venture capital for three decades, so he knows how to spot a bubble. Too many billion-dollar start-ups is a big sign.

  • Medtronic closes on Covidien deal: CEO   Tuesday, 27 Jan 2015 | 9:47 AM ET
    Medtronic closes on Covidien deal: CEO

    Omar Ishrak, Medtronic chairman and CEO, discusses the strategic plan behind its merger with Covidien and the headwinds caused by the strong U.S. dollar.

  • Goldman Sachs: Watch out for energy M&A in 2015 Monday, 12 Jan 2015 | 7:14 AM ET
    A derrick hand removes the the plastic caps off the threaded ends of pipe used in the drilling process in Knox County, Ohio.

    Healthcare M&A looks set to be strong again this year, following deals from Shire and Roche. But Goldman Sachs says energy's a sector to watch too.

  • Tax inversion anyone? A year in M&A Monday, 29 Dec 2014 | 1:20 AM ET

    Mergers and acquisitions broke a seven-year losing streak in 2014, with $3.48 trillion worth of deals. CNBC looks at some of the year's highlights.

  • Dec 4- The top U.S. patent appeals court has thrown out a $176 million award for healthcare company Covidien Plc in a dispute with a Johnson& Johnson subsidiary over surgical instruments. Judge Sharon Prost of the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., ruled on Thursday that Covidien's patent claims, which involve surgical cutting tools...

  • Treasuries fell on Tuesday, with prices pressured by a Wall Street rally and institutional investors readying for a $6 billion corporate bond deal from leading retailer Amazon. "Today was primarily about the rebound in equity prices," said Ian Lyngen, senior government bond strategist at CRT Capital in Stamford, Connecticut. "There is a lot of corporate issuance...

  • Treasuries, which posted strong returns during November, also declined on Monday, when Medtronic Inc priced $17 billion of senior notes. "There is a lot of corporate issuance that's being hedged and that's applying a lot of pressure," said Sean Murphy, a Treasuries trader at Societe Generale in New York. According to IFR, a unit of Thomson Reuters, Bank of America and...

  • WASHINGTON, Nov 26- Medtronic Inc has won U.S. antitrust approval to buy Dublin- based Covidien Plc on condition that it sell its drug-coated balloon catheter business, the Federal Trade Commission said on Wednesday. Medtronic and Covidien shareholders will vote on the merger on Jan. 6. Medtronic is the world's largest stand-alone medical device maker, with a...

  • FACTBOX-Recent tax inversion proposals Tuesday, 25 Nov 2014 | 1:19 PM ET

    Medical technology company Medtronic Inc said on Nov. 18 that its plan to acquire and adopt the tax domicile of Ireland's Covidien Plc was on track to close in 2015.. High-tech manufacturer Applied Materials Inc plans to buy Japanese rival Tokyo Electron Ltd and reincorporate in the Netherlands. Burger King Worldwide Inc plans to acquire Canadian coffee and...

  • LONDON/ NEW YORK, Nov 18- Deutsche Bank on Tuesday priced US $1.5 billion of bonds that convert into equity, fortifying its capital strength and its leverage ratio in particular. It was sized at the upper end of the US $1 billion to US $1.5 billion range flagged to investors. Of the rest, around 25% was sold into Asia and the rest into Europe.

  • Midday movers: Allergan, Apple, Fluor & more Tuesday, 18 Nov 2014 | 12:56 PM ET
    New York Stock Exchange NYSE

    Some of Tuesday midday movers:

  • Medtronic meets Street; Covidien deal on track Tuesday, 18 Nov 2014 | 12:10 PM ET
    Medtronic's CoreValve Evolut

    Medtronic posted a profit that was in line with expectations and said its $42.9 billion purchase of hospital products maker Covidien remains on track.

  • Nov 18- Medtronic Inc posted a quarterly profit that was in line with analyst expectations, helped by sales of new heart devices, and said its $42.9 billion purchase of hospital products maker Covidien Plc remains on track to close early next year. But Medtronic executives said they remain fully committed to buying Dublin- based Covidien and are focused on...

  • Early Movers: HD, MDT, EA, ZTS, GPRO, IBM & more Tuesday, 18 Nov 2014 | 9:01 AM ET

    Some of the names on the move ahead of the open.

  • Stock futures little moved after Home Depot, data Tuesday, 18 Nov 2014 | 8:54 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Wall Street looked set for a higher open on Tuesday, after Dow component Home Depot reported numbers that were better than expected.

  • Why a Santa rally might not be in the cards Tuesday, 18 Nov 2014 | 6:03 AM ET
    Traders on the floor of the New York Stock Exchange.

    Many traders expect stocks to rally into the year-end, but the current complacency may be signaling a late year Santa rally won't happen this year.

  • Why a Santa rally might not be in the cards Monday, 17 Nov 2014 | 6:32 PM ET
    Traders on the floor of the New York Stock Exchange.

    Many traders expect stocks to rally into the year-end, but the current complacency may be signaling a late year Santa rally won't happen this year.

  • WASHINGTON, Nov 12- Republicans in the U.S. Congress will soon move to kill a medical device tax imposed less than two years ago under President Barack Obama's healthcare law, congressional aides and analysts said on Wednesday. Though no full-scale repeal of Obamacare is expected, even with the Senate now under Republican control, the move against the tax is part...